← Back to Search

JAK/T-cell/IL-6 for Rheumatoid Arthritis (PREDICT Trial)

N/A
Recruiting
Research Sponsored by Scipher Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

PREDICT Trial Summary

Prospective, multi-center-observational study conducted within the US, collecting patient samples for research and development to train, test, and validate precision medicine classifiers. These molecular signature response classifiers (MSRC) aim to predict response status to JAK, T-cell, and IL-6 inhibitor therapies in patients with rheumatoid arthritis (RA).

Eligible Conditions
  • Rheumatoid Arthritis

PREDICT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The rate of MSRC to predict the patients response

PREDICT Trial Design

1Treatment groups
Experimental Treatment
Group I: JAK/T-cell/IL-6Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Scipher MedicineLead Sponsor
1 Previous Clinical Trials
613 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
613 Patients Enrolled for Rheumatoid Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~733 spots leftby Jun 2025